Company Filing History:
Years Active: 2023
Title: Prajit Limsirichai: Innovator in Oncolytic Virus Research
Introduction
Prajit Limsirichai is a notable inventor based in Washington, DC. He has made significant contributions to the field of immunotherapy, particularly through his work on recombinant viruses. His innovative approach aims to harness the power of oncolytic viruses to combat tumors.
Latest Patents
Limsirichai holds a patent for a recombinant vaccinia virus and methods of use thereof. This patent describes a replication-competent, recombinant oncolytic vaccinia virus, along with compositions that include the virus. The primary application of this invention is to induce oncolysis in individuals with tumors, showcasing its potential in cancer treatment.
Career Highlights
Prajit Limsirichai is associated with Ignite Immunotherapy, Inc., where he continues to advance his research in the field. His work is pivotal in developing therapies that utilize oncolytic viruses to target and destroy cancer cells.
Collaborations
Limsirichai collaborates with esteemed colleagues such as David H. Kirn and Liliana Maruri Avidal. These partnerships enhance the research efforts and contribute to the innovative environment at Ignite Immunotherapy.
Conclusion
Prajit Limsirichai is a key figure in the development of oncolytic virus therapies, with a focus on improving cancer treatment through innovative research. His contributions are paving the way for new therapeutic options in oncology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.